Musim Mas and NTU Singapore Launch Multi-Year Study to Understand How Sustainability Spreads Among Smallholder Farmers

Musim Mas and NTU Singapore Launch Multi-Year Study to Understand How Sustainability Spreads Among Smallholder Farmers

A multi-year collaboration to study what motivates smallholder farmers to adopt sustainable palm oil practices, and how such behaviours can spread across farming communities in Indonesia. SINGAPORE, Feb. 9, 2026 /PRNewswire/ -- Musim Mas Group and...

UN Representatives from 17 Nations Visit BEDI to Study China's Leading Practices in Urban AI Industry Operations

UN Representatives from 17 Nations Visit BEDI to Study China's Leading Practices in Urban AI Industry Operations

BEIJING, Feb. 5, 2026 /PRNewswire/ -- The United Nations International Digital Economy Governance and Leadership Capacity Building Programme officially opened at Beijing Electronic Digital & Intelligence (BEDI). A delegation of 34 ministerial...

Study: "Reaching out" Tops the List of Most Overused Email Buzzwords

Study: "Reaching out" Tops the List of Most Overused Email Buzzwords

ZeroBounce analyzed more than one million real work emails to uncover the most common email cliches. SANTA BARBARA, Calif., Jan. 21, 2026 /PRNewswire/ -- "Reaching out" is the most overused email cliche, with "checking in" and "follow up" close...

TOEFL iBT® and Study.com Launch Official TOEFL Test Prep Ahead of Enhanced Test Debut on January 21, 2026

TOEFL iBT® and Study.com Launch Official TOEFL Test Prep Ahead of Enhanced Test Debut on January 21, 2026

PRINCETON, N.J. and MOUNTAIN VIEW, Calif., Nov. 20, 2025 /PRNewswire/ -- ETS's TOEFL iBT, the world's first and most respected academic English test, has partnered with Study.com, an award-winning online learning platform, to launch the Official...

Klotho Neurosciences, Inc. and the Okinawa Research Center for Longevity Science, Leading Experts on the Okinawa "Blue Zone", Announce a Plan to Study Tissue Levels of the Human Klotho Gene and Protein in the World's Longest-Lived Population

Klotho Neurosciences, Inc. and the Okinawa Research Center for Longevity Science, Leading Experts on the Okinawa "Blue Zone", Announce a Plan to Study Tissue Levels of the Human Klotho Gene and Protein in the World's Longest-Lived Population

NEW YORK, June 24, 2025 /PRNewswire/ -- Klotho Neuroscience, Inc. (NASDAQ: KLTO), a US-based biogenetics company developing cell and gene- based treatments to address neurological conditions, including ALS, Alzheimer's Disease (AD) and Parkinson's...

Dizal Completes Enrollment for its Phase III Pivotal Study of Sunvozertinib vs. Platinum Doublet in Treatment Naïve NSCLC Patients with EGFR Exon20 Insertional Mutations

Dizal Completes Enrollment for its Phase III Pivotal Study of Sunvozertinib vs. Platinum Doublet in Treatment Naïve NSCLC Patients with EGFR Exon20 Insertional Mutations

SHANGHAI, June 19, 2025 /PRNewswire/ -- Dizal announced the completion of patient enrollment for its WU-KONG28 clinical trial: a multinational, randomized phase III study evaluating the efficacy and safety of sunvozertinib versus platinum-based...

Bai Capital Brings U.S. Green Card Solutions to Vietnamese Families at EB-5 Event in Hanoi

Bai Capital Brings U.S. Green Card Solutions to Vietnamese Families at EB-5 Event in Hanoi

Over 30 investors attended the private seminar organized by BAI Capital Vietnam, unlocking pathways to U.S. Green Cards and access to the U.S. public university system. HANOI, Vietnam, June 17, 2025 /PRNewswire/ -- On June 7, BAI Capital hosted the...

Enertis Applus+ Study: LONGi BC Modules Outperform TOPCon in LCOE, Driving Higher Commercial Value

Enertis Applus+ Study: LONGi BC Modules Outperform TOPCon in LCOE, Driving Higher Commercial Value

SEVILLE, Spain, June 10, 2025 /PRNewswire/ -- Global technical engineering consultancy Enertis Applus+ has released a comprehensive analysis of a 47MW single-axis tracker PV project in Seville, Spain, comparing the commercial performance of...

The British Medical Journal Publishes Study Results on Sacituzumab Tirumotecan for Previously Treated EGFR-Mutant Advanced NSCLC

The British Medical Journal Publishes Study Results on Sacituzumab Tirumotecan for Previously Treated EGFR-Mutant Advanced NSCLC

CHENGDU, China, June 7, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", 6990.HK) today announced that results from its registrational study (OptiTROP-Lung03) evaluating sacituzumab tirumotecan (sac-TMT)...

menu
menu